dc.creator | Sovtić, D. D. | |
dc.creator | Tasić, Ljiljana | |
dc.creator | Stojanović, S. | |
dc.date.accessioned | 2019-09-02T11:03:52Z | |
dc.date.available | 2019-09-02T11:03:52Z | |
dc.date.issued | 2006 | |
dc.identifier.issn | 1098-3015 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/706 | |
dc.description.abstract | OBJECTIVE: Is to analyze trends in prescription habits and
rational use of antibiotics in different population groups, as well
as expenditure data regarding drug policy changes. METHODS:
We used database from Public pharmacy chain—Pharmacy Insti-
tution Belgrade (1.5 M population) with conventional data
grouping and database analysis. All information on antibiotics
was based on prescriptions which were reimbursed by local
Health Insurance Fund (HIF). The calculations included: DDD
methods, monetary cost for months, quarters and years level
(2004–2005). RESULTS: The use of antibiotics expressed in
DDD/1000 inhabitants/day units reveals that in Belgrade popu-
lation the most prescribed antibiotic is amoxicillin during two
years (4.77 in 2004; 4.37 in 2005). The biggest increase has been
shown in the use of azithromycin (from 0.25 in 2004 to 0.75 in
2005). Expenditure of antibiotics was analyzed between six pop-
ulation groups (three children’s, two work ages, one senior) and
expressed as % of all antibiotics used. The highest financial cost
has been found in group of 19–50 years old in both years with
levels 26.11% and 32.27% respectively. The first three anti-
biotics with highest financial share (monetary cost in % of all
antibiotics) are cefalexin 27.46%, erythromycin 17.73%, amox-
icillin 13.57% (2004); cefalexin 21.06%, erythromycin 14.59%,
azithromycin 14.11% (2005). CONCLUSIONS: Analysis and
evaluation of the data has shown that there had been increase in
expenditure of antibiotics in these periods particularly in age
group 19–50. The biggest increase is notified in the use of
azithromycin both in financial values and DDD units, conducted
by drug policy changes (reimbursement list). Monitoring of the
antibiotics use in longer period can provide further useful infor-
mation about rational use of this group of medicines. | |
dc.publisher | Elsevier | |
dc.rights | openAccess | |
dc.source | Value in Health | |
dc.title | Indicator of antibiotic use in Public pharmacy chain Belgrade | en |
dc.type | conferenceObject | |
dc.rights.license | ARR | |
dcterms.abstract | Стојановић, С.; Совтић, Д. Д.; Тасић, Љиљана; | |
dc.citation.volume | 9 | |
dc.citation.issue | 6 | |
dc.citation.spage | A306 | |
dc.citation.epage | A306 | |
dc.citation.other | 9(6): - | |
dc.citation.rank | aM21 | |
dc.description.other | POSTER SESSION II | |
dc.description.other | INFECTION | |
dc.identifier.wos | 000240922000378 | |
dc.identifier.doi | 10.1016/S1098-3015(10)63525-5 | |
dc.identifier.fulltext | http://farfar.pharmacy.bg.ac.rs/bitstream/id/10610/Indicator_of_antibiotic_pub_2006.pdf | |
dc.type.version | publishedVersion | |